Physiological role of HMG-CoA reductase in regulating egg production by Schistosoma mansoni.
Pathological lesions observed in humans infected with Schistosoma mansoni are due to the eggs produced by the female parasite. Mevinolin, a potent inhibitor of the enzyme hydroxymethylglutaryl-CoA (HMG-CoA) reductase, blocks egg production by this parasite. In this report, we demonstrate that cholesterol precursors, mevalonate and farnesol, stimulate egg production by the female parasite and that these precursors can reverse the mevinolin-induced inhibition of egg production. Because the parasite cannot synthesize cholesterol, we incubated parasites in a culture media containing radiolabeled acetate with and without mevinolin. We isolated nonsterol lipids from the parasite and observed that mevinolin dramatically reduced the conversion of acetate into the polyisoprenoid (dolichols) lipids of the parasite. Dolichols and other nonsterol lipids did not stimulate egg production. HMG-CoA reductase activity was observed in homogenates of the parasite and was inhibited by mevinolin (Ki = 52 nM), but its activity was tripled when the parasite was chronically exposed to low doses of the drug. Parasites with increased reductase activity produced five to six times more eggs. Lastly, chronic administration of large doses of mevinolin to infected mice resulted in a marked reduction of the pathology associated with the infection. These results suggest that egg production in S. mansoni is associated with the parasite's HMG-CoA reductase activity and that a nonsterol lipid produced in the biochemical pathway regulated by this enzyme stimulates egg production.
Department of Microbiology, Michigan State University, East Lansing 48824.
E A
EA
Vandewaa
G
G
Mills
G Z
GZ
Chen
L A
LA
Foster
J L
JL
Bennett
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005204:Farnesol / Q000494:pharmacology; D005260:Female; D006903:Hydroxymethylglutaryl CoA Reductases / Q000502:physiology*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D050356:Lipid Metabolism; D008148:Lovastatin / Q000494:pharmacology; D051379:Mice; D010063:Ovum / Q000502:physiology*; D012550:Schistosoma mansoni / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D014018:Tissue Distribution
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D005204:Farnesol; D008148:Lovastatin; D006903:Hydroxymethylglutaryl CoA Reductases